162 related articles for article (PubMed ID: 24402378)
1. Inventory of economic evaluation of head and neck oncology from the German perspective.
Kurzweg T; Knecht R
Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2611-6. PubMed ID: 24402378
[TBL] [Abstract][Full Text] [Related]
2. Economic analyses in squamous cell carcinoma of the head and neck: a review of the literature from a clinical perspective.
de Souza JA; Santana IA; de Castro G; de Lima Lopes G; Tina Shih YC
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):989-996. PubMed ID: 25035201
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of neoadjuvant chemotherapy in locally advanced operable head and neck cancer followed by surgery and postoperative radiotherapy: a Markov model-based decision analysis.
Himmel M; Hartmann M; Guntinas-Lichius O
Oncology; 2013; 84(6):336-41. PubMed ID: 23652024
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
Retèl VP; van der Molen L; Hilgers FJ; Rasch CR; L'Ortye AA; Steuten LM; van Harten WH
BMC Cancer; 2011 Nov; 11():475. PubMed ID: 22051143
[TBL] [Abstract][Full Text] [Related]
5. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
Meregaglia M; Cairns J; Licitra L; Bossi P
Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
[TBL] [Abstract][Full Text] [Related]
6. [Economic assessments of head and neck cancers: a review].
Selke B; Allenet B; Bercez C; Bogillot O; Lebrun T; Lefebvre JL
Bull Cancer; 2001 Aug; 88(8):759-64. PubMed ID: 11578944
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
[TBL] [Abstract][Full Text] [Related]
8. Quality in head neck oncology.
Wiegand S; Dietz A
Laryngorhinootologie; 2020 Mar; 99(S 01):S60-S106. PubMed ID: 32384563
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of head and neck cancer. A literature review.
Lee JM; Turini M; Botteman MF; Stephens JM; Pashos CL
Eur J Health Econ; 2004 Feb; 5(1):70-80. PubMed ID: 15452768
[TBL] [Abstract][Full Text] [Related]
10. Treatment costs for patients with head and neck cancer.
Suen JY; Jackson MJ; Porr MJ
Arch Otolaryngol; 1979 Mar; 105(3):160-3. PubMed ID: 420657
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of using TheraBite in a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
Retèl VP; van der Molen L; Steuten LM; van den Brekel MW; Hilgers FJ
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):709-18. PubMed ID: 25666587
[TBL] [Abstract][Full Text] [Related]
12. Clinical economics of head and neck malignancies.
Sherman EJ; Ruchlin HS; Holden JS; Pfister DG
Hematol Oncol Clin North Am; 1999 Aug; 13(4):867-81. PubMed ID: 10494519
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of current and emerging approaches in the field of larynx preservation.
Denaro N; Russi EG; Lefebvre JL; Merlano MC
Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
[TBL] [Abstract][Full Text] [Related]
14. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.
Chan AL; Leung HW; Huang SF
Clin Drug Investig; 2011 Oct; 31(10):717-26. PubMed ID: 21744880
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary approaches in the management of advanced head and neck tumors: state of the art.
Gibson MK; Forastiere AA
Curr Opin Oncol; 2004 May; 16(3):220-4. PubMed ID: 15069316
[TBL] [Abstract][Full Text] [Related]
17. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
[TBL] [Abstract][Full Text] [Related]
18. Curative treatment of head and neck squamous cell carcinoma : Organ preservation strategies in clinical routine in German-speaking countries.
Kurzweg T; Kimmeyer J; Knecht R; Hoffmann TK; Busch CJ; Lörincz BB; Schuler PJ; Laban S
HNO; 2016 Jul; 64(7):501-7. PubMed ID: 27357174
[TBL] [Abstract][Full Text] [Related]
19. Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
Jansen F; Krebber AM; Coupé VM; Cuijpers P; de Bree R; Becker-Commissaris A; Smit EF; van Straten A; Eeckhout GM; Beekman AT; Leemans CR; Verdonck-de Leeuw IM
J Clin Oncol; 2017 Jan; 35(3):314-324. PubMed ID: 27918712
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer.
Beck ACC; van Harten WH; van den Brekel MWM; Navran A; Retèl VP
Laryngoscope; 2021 Feb; 131(2):E509-E517. PubMed ID: 32776557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
